{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:28:05Z","timestamp":1790962085566,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Gerontology and Geriatrics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.archger.2024.105602","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:29:22Z","timestamp":1723501762000},"page":"105602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry"],"prefix":"10.1016","volume":"128","author":[{"given":"Vincenzo","family":"Arcoraci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Rottura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana Maria","family":"Gianguzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egidio","family":"Imbalzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Natoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiano","family":"Argano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Irrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.archger.2024.105602_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2022.104661","article-title":"Frailty and outcomes in older adults with non-valvular atrial fibrillation from the ANAFIE registry","volume":"101","author":"Akishita","year":"2022","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"7","key":"10.1016\/j.archger.2024.105602_bib0002","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.clinthera.2017.05.358","article-title":"Effectiveness and safety of non\u2013vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: A systematic review and meta-analyses","volume":"39","author":"Almutairi","year":"2017","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1016\/j.archger.2024.105602_bib0003","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.archger.2024.105602_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.749711","article-title":"Kidney disease management in the hospital setting: A focus on inappropriate drug prescriptions in older patients","volume":"12","author":"Arcoraci","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.archger.2024.105602_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.876693","article-title":"Beta-blocker use in older hospitalized patients affected by heart failure and chronic obstructive pulmonary disease: An Italian survey from the REPOSI register","volume":"9","author":"Arcoraci","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"4","key":"10.1016\/j.archger.2024.105602_bib0006","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/jcpt.13391","article-title":"Adverse drug reactions with oral anticoagulants: Data from Sicilian spontaneous reporting system database","volume":"46","author":"Barbieri","year":"2021","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"6","key":"10.1016\/j.archger.2024.105602_bib0007","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.118.035012","article-title":"Early risks of death, stroke\/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation","volume":"139","author":"Bassand","year":"2019","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.archger.2024.105602_bib0008","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.archger.2024.105602_bib0009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40520-016-0569-7","article-title":"Effects of oral anticoagulant therapy in older medical in-patients with atrial fibrillation: A prospective cohort observational study","volume":"29","author":"Bo","year":"2017","journal-title":"Aging Clinical and Experimental Research"},{"issue":"24","key":"10.1016\/j.archger.2024.105602_bib0010","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.3390\/jcm11247423","article-title":"Oral anticoagulant use and appropriateness in elderly patients with atrial fibrillation in complex clinical conditions: ACONVENIENCE study","volume":"11","author":"Bonanad","year":"2022","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10.1016\/j.archger.2024.105602_bib0011","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s12325-021-01769-9","article-title":"Unmet clinical needs in elderly patients receiving direct oral anticoagulants for stroke prevention in non-valvular atrial fibrillation","volume":"38","author":"Botto","year":"2021","journal-title":"Advances in Therapy"},{"issue":"2","key":"10.1016\/j.archger.2024.105602_bib0012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/agm2.12214","article-title":"Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review","volume":"6","author":"Bul","year":"2023","journal-title":"Aging Medicine"},{"issue":"S 01","key":"10.1016\/j.archger.2024.105602_bib0013","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1055\/s-0038-1635084","article-title":"Understanding the value of real-world evidence: Focus on stroke prevention in atrial fibrillation with rivaroxaban","volume":"118","author":"Camm","year":"2018","journal-title":"Thrombosis and Haemostasis"},{"issue":"4","key":"10.1016\/j.archger.2024.105602_bib0014","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.archger.2024.105602_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejim.2018.06.001","article-title":"Implementation of the frailty index in hospitalized older patients: Results from the REPOSI register","volume":"56","author":"Cesari","year":"2018","journal-title":"European Journal of Internal Medicine"},{"issue":"5","key":"10.1016\/j.archger.2024.105602_bib0016","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1357633X18822575","article-title":"Pharmacist-led telehealth disease management program for patients with diabetes and depression","volume":"26","author":"Cohen","year":"2020","journal-title":"Journal of Telemedicine and Telecare"},{"issue":"12","key":"10.1016\/j.archger.2024.105602_bib0017","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.archger.2024.105602_bib0018","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/13696998.2020.1832099","article-title":"Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA","volume":"23","author":"Deitelzweig","year":"2020","journal-title":"Journal of Medical Economics"},{"issue":"3","key":"10.1016\/j.archger.2024.105602_bib0019","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: Evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"The Journals of Gerontology Series A: Biological Sciences and Medical Sciences"},{"issue":"11","key":"10.1016\/j.archger.2024.105602_bib0020","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1093\/europace\/eux288","article-title":"Frailty syndrome: An emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey","volume":"19","author":"Fumagalli","year":"2017","journal-title":"EP Europace"},{"issue":"31","key":"10.1016\/j.archger.2024.105602_bib0021","doi-asserted-by":"crossref","first-page":"e16560","DOI":"10.1097\/MD.0000000000016560","article-title":"Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant)","volume":"98","author":"Ga\u017eov\u00e1","year":"2019","journal-title":"Medicine"},{"issue":"22","key":"10.1016\/j.archger.2024.105602_bib0022","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1016\/j.archger.2024.105602_bib0023","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.archger.2024.105602_bib0024","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.archger.2024.105602_bib0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jamda.2014.12.008","article-title":"Thromboembolic prevention in frail elderly patients with atrial fibrillation: A practical algorithm","volume":"16","author":"Granziera","year":"2015","journal-title":"Journal of the American Medical Directors Association"},{"issue":"4","key":"10.1016\/j.archger.2024.105602_bib0026","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/bcp.15582","article-title":"Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort study","volume":"89","author":"Grymonprez","year":"2023","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.archger.2024.105602_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.583311","article-title":"Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: A systematic review and meta-analysis","volume":"11","author":"Grymonprez","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"12","key":"10.1016\/j.archger.2024.105602_bib0028","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.archger.2024.105602_bib0029","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"European Heart Journal"},{"issue":"06","key":"10.1016\/j.archger.2024.105602_bib0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1055\/s-0039-1683422","article-title":"Non-vitamin K oral anticoagulants in comparison to phenprocoumon in geriatric and non-geriatric patients with non-valvular atrial fibrillation","volume":"119","author":"Hohmann","year":"2019","journal-title":"Thrombosis and Haemostasis"},{"issue":"03","key":"10.1016\/j.archger.2024.105602_bib0031","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1160\/TH17-10-0733","article-title":"Effectiveness and safety of non\u2013vitamin K oral anticoagulants in comparison to phenprocoumon: data from 61,000 patients with atrial fibrillation","volume":"118","author":"Hohnloser","year":"2018","journal-title":"Thrombosis and Haemostasis"},{"issue":"11","key":"10.1016\/j.archger.2024.105602_bib0032","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archinte.160.11.1612","article-title":"Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation","volume":"160","author":"Hylek","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"11","key":"10.1016\/j.archger.2024.105602_bib0033","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/ggi.13058","article-title":"Clinical frailty is independently associated with non-prescription of anticoagulants in older patients with atrial fibrillation","volume":"17","author":"Induruwa","year":"2017","journal-title":"Geriatrics & Gerontology International"},{"issue":"3","key":"10.1016\/j.archger.2024.105602_bib0034","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.amepre.2021.08.021","article-title":"Pharmacist interventions for medication adherence: Community guide economic reviews for cardiovascular disease","volume":"62","author":"Jacob","year":"2022","journal-title":"American Journal of Preventive Medicine"},{"issue":"9","key":"10.1016\/j.archger.2024.105602_bib0035","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation","volume":"174","author":"Kim","year":"2021","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.archger.2024.105602_bib0036","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century","volume":"127","author":"Kornej","year":"2020","journal-title":"Circulation Research"},{"issue":"07","key":"10.1016\/j.archger.2024.105602_bib0037","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: Past, present and future","volume":"117","author":"Lip","year":"2017","journal-title":"Thrombosis and Haemostasis"},{"issue":"12","key":"10.1016\/j.archger.2024.105602_bib0038","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1161\/STROKEAHA.118.020232","article-title":"Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients","volume":"49","author":"Lip","year":"2018","journal-title":"Stroke; A Journal of Cerebral Circulation"},{"issue":"47","key":"10.1016\/j.archger.2024.105602_bib0039","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/eurheartj\/ehu374","article-title":"Prognosis and treatment of atrial fibrillation patients by European cardiologists: One year follow-up of the EURObservational research programme-atrial fibrillation general registry pilot phase (EORP-AF Pilot registry)","volume":"35","author":"Lip","year":"2014","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1016\/j.archger.2024.105602_bib0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.archger.2024.105602_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1261183","article-title":"The safety and efficacy of direct oral anticoagulants among chronic kidney disease patients on dialysis with non-valvular atrial fibrillation: A meta-analysis","volume":"10","author":"Mapili","year":"2023","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"1","key":"10.1016\/j.archger.2024.105602_bib0042","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12916-021-02067-5","article-title":"Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: A cohort study","volume":"19","author":"Mitchell","year":"2021","journal-title":"BMC Medicine"},{"issue":"6","key":"10.1016\/j.archger.2024.105602_bib0043","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.hlc.2015.12.002","article-title":"The impact of frailty on mortality, length of stay and re-hospitalisation in older patients with atrial fibrillation","volume":"25","author":"Nguyen","year":"2016","journal-title":"Heart, Lung and Circulation"},{"issue":"7372","key":"10.1016\/j.archger.2024.105602_bib0044","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.325.7372.1073","article-title":"Oral anticoagulation and risk of death: A medical record linkage study","volume":"325","author":"Oden","year":"2002","journal-title":"BMJ (Clinical research ed.)"},{"issue":"3","key":"10.1016\/j.archger.2024.105602_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1253\/circj.CJ-20-0373","article-title":"Impact of frailty on bleeding events related to anticoagulation therapy in patients with atrial fibrillation","volume":"85","author":"Ohta","year":"2021","journal-title":"Circulation Journal"},{"issue":"1","key":"10.1016\/j.archger.2024.105602_bib0046","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cjca.2021.09.021","article-title":"The introduction of direct oral anticoagulants has not resolved treatment gaps for frail patients with nonvalvular atrial fibrillation","volume":"38","author":"Orlandi","year":"2022","journal-title":"Canadian Journal of Cardiology"},{"issue":"08","key":"10.1016\/j.archger.2024.105602_bib0047","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1160\/TH08-11-0730","article-title":"Bleeding with anticoagulation therapy \u2013 who is at risk, and how best to identify such patients","volume":"102","author":"Palareti","year":"2009","journal-title":"Thrombosis and Haemostasis"},{"issue":"10","key":"10.1016\/j.archger.2024.105602_bib0048","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.archger.2024.105602_bib0049","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-005-0972-z","article-title":"Statin-macrolide interaction risk: A population-based study throughout a general practice database","volume":"61","author":"Piacentini","year":"2005","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"12","key":"10.1016\/j.archger.2024.105602_bib0050","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.mayocp.2019.06.012","article-title":"Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use","volume":"94","author":"Proietti","year":"2019","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.archger.2024.105602_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101652","article-title":"Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients","volume":"79","author":"Proietti","year":"2022","journal-title":"Ageing Research Reviews"},{"issue":"6","key":"10.1016\/j.archger.2024.105602_bib0052","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afr097","article-title":"Attitudes of physicians regarding anticoagulation for atrial fibrillation: A systematic review","volume":"40","author":"Pugh","year":"2011","journal-title":"Age and Ageing"},{"issue":"10","key":"10.1016\/j.archger.2024.105602_bib0053","doi-asserted-by":"crossref","first-page":"e30787","DOI":"10.1016\/j.heliyon.2024.e30787","article-title":"Chronic kidney disease progression in diabetic patients: Real world data in general practice","volume":"10","author":"Rottura","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.archger.2024.105602_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115020","article-title":"Prescriptive behavior of non-vitamin K oral anticoagulants in patients affected by atrial fibrillation in general practice","volume":"165","author":"Rottura","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.archger.2024.105602_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.858385","article-title":"Pharmacological treatment of diabetic and non-diabetic patients with coronary artery disease in the real world of general practice","volume":"13","author":"Rottura","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.archger.2024.105602_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.749686","article-title":"Management of high cardiovascular risk in diabetic patients: Focus on low density lipoprotein cholesterol and appropriate drug use in general practice","volume":"8","author":"Rottura","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"9921","key":"10.1016\/j.archger.2024.105602_bib0057","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.archger.2024.105602_bib0058","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014108","article-title":"Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: The SAGE-AF study","volume":"9","author":"Sanghai","year":"2020","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.archger.2024.105602_bib0059","article-title":"Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation","author":"S\u00f8gaard","year":"2023","journal-title":"European Heart Journal - Cardiovascular Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.archger.2024.105602_bib0060","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"EP Europace"},{"issue":"8","key":"10.1016\/j.archger.2024.105602_bib0061","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0895-4356(96)00025-X","article-title":"Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis","volume":"49","author":"Sun","year":"1996","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1016\/j.archger.2024.105602_bib0062","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"European Journal of Epidemiology"},{"key":"10.1016\/j.archger.2024.105602_bib0063","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.archger.2017.05.014","article-title":"Dementia correlates with anticoagulation underuse in older patients with atrial fibrillation","volume":"72","author":"Viscogliosi","year":"2017","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"6","key":"10.1016\/j.archger.2024.105602_bib0064","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1532-5415.2006.00745.x","article-title":"Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American geriatrics society\/national institute on aging research conference on frailty in older adults","volume":"54","author":"Walston","year":"2006","journal-title":"Journal of the American Geriatrics Society"},{"issue":"2","key":"10.1016\/j.archger.2024.105602_bib0065","first-page":"84","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation","volume":"1","author":"Wan","year":"2008","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"2","key":"10.1016\/j.archger.2024.105602_bib0066","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: A systematic review and meta-analysis","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age and Ageing"},{"issue":"22","key":"10.1016\/j.archger.2024.105602_bib0067","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American society of hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Advances"},{"issue":"2","key":"10.1016\/j.archger.2024.105602_bib0068","doi-asserted-by":"crossref","DOI":"10.1136\/heartasia-2019-011212","article-title":"The influence of frailty under direct oral anticoagulant use in patients with atrial fibrillation","volume":"11","author":"Yamamoto","year":"2019","journal-title":"Heart Asia"},{"key":"10.1016\/j.archger.2024.105602_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2019.00175","article-title":"Atrial fibrillation in older people: Concepts and controversies","volume":"6","author":"Zathar","year":"2019","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.archger.2024.105602_bib0070","article-title":"Effectiveness and safety of DOACs vs. warfarin in patients with atrial fibrillation and frailty: A systematic review and meta-analysis","volume":"9","author":"Zeng","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.archger.2024.105602_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/5951262","article-title":"anticoagulation control in older atrial fibrillation patients receiving vitamin K antagonist therapy for stroke prevention","volume":"2022","author":"Zulkifly","year":"2022","journal-title":"International Journal of Clinical Practice"}],"container-title":["Archives of Gerontology and Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494324002784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494324002784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T20:48:48Z","timestamp":1730407728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167494324002784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":71,"alternative-id":["S0167494324002784"],"URL":"https:\/\/doi.org\/10.1016\/j.archger.2024.105602","relation":{},"ISSN":["0167-4943"],"issn-type":[{"value":"0167-4943","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry","name":"articletitle","label":"Article Title"},{"value":"Archives of Gerontology and Geriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archger.2024.105602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105602"}}